Back to Browse Journals » Vascular Health and Risk Management » Volume 8

ESR rate can be a marker for coronary artery disease

Authors Eghbal Eftekhaari T

Received 10 October 2012

Accepted for publication 10 October 2012

Published 18 December 2012 Volume 2012:8 Pages 669—670

DOI http://dx.doi.org/10.2147/VHRM.S39006

Checked for plagiarism Yes

Tasnim Eghbal Eftekhaari

Clinical Research Development Center of Shahid Mohammadi Hospital, Research Center for Cardiovascular Diseases, Department of Research and Technology, Hormozgan University of Medical Sciences, Bandar-e-Abbas, Iran

The aim of Yayan’s1 study was to utilize the erythrocyte sedimentation rate (ESR) as a rapid guide to identify patients with acute coronary syndrome (ACS) or myocardial infarction. ESR is arguably a nonspecific biomarker which is elevated in almost every condition. Prakash et al2 have pointed to conflicting reports in the literature documenting the tendency of patients with periodontitis to develop anemia. Hence, this study was undertaken to assess whether periodontitis can cause an anemic state by evaluating and comparing the red blood cell count and levels of hemoglobin, hematocrit, ESR, serum iron, and serum ferritin between subjects with and without periodontitis, anemia, rheumatoid arthritis, and other hematologic conditions.1 However, this study shows that there is no statistically significant difference between rates of ESR in men and women. The purpose of referring to this reference is that most elderly people suffer from periodontitis and this condition is not negligible given that many older people also suffer for concomitant ischemic heart disease. Inflammation arising within the gastrointestinal tract may be of great importance in the pathogenesis of irritable bowel syndrome,2 regarding this fact that ESR is commonly used to assess the acute phase response,3 this acute phase response may be nonspecific. Elevated ESR is seen more often in elderly patients than in their younger counterparts3 (imagine an elderly patient with elevated ESR and consider whether ESR would be used as the sole basis for diagnosis of heart pain? Of course not!). ESR elevated concomitantly with C-reactive protein is used to confirm adult-onset Still’s disease.4 In an adult who is a heavy smoker with dyslipidemia, a personal history of Still’s disease, and a family history of ischemic heart disease, would you consider Still’s disease or ACS first?

View original paper by Yayan.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Other article by this author:

Efficacy of musculoskeletal injections given by primary care providers in the office

Eghbal Eftekhaari T, Nazarnejhad M, Ghasemzadeh I

International Journal of General Medicine 2013, 6:773-775

Published Date: 16 September 2013

Readers of this article also read:

Complications of the endovascular management of acute ischemic stroke

Gill HL, Siracuse JJ, Parrack IK, Huang ZS, Meltzer AJ

Vascular Health and Risk Management 2014, 10:675-681

Published Date: 28 November 2014

Surgical therapies for corneal perforations: 10 years of cases in a tertiary referral hospital

Yokogawa H, Kobayashi A, Yamazaki N, Masaki T, Sugiyama K

Clinical Ophthalmology 2014, 8:2165-2170

Published Date: 29 October 2014

Magnetoledtherapy in the treatment of wounds after surgical procedures of the knee joint

Pasek J, Pasek T, Sieroń A

Therapeutics and Clinical Risk Management 2014, 10:717-720

Published Date: 2 September 2014

Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug

Wang H, Gu W, Xiao N, Ye L, Xu Q

International Journal of Nanomedicine 2014, 9:1433-1442

Published Date: 18 March 2014

Controlled-release approaches towards the chemotherapy of tuberculosis

Saifullah B, Hussein MZ, Hussein Al Ali SH

International Journal of Nanomedicine 2012, 7:5451-5463

Published Date: 12 October 2012

Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension

Topouchian J, Agnoletti D, Blacher J, Youssef A, Ibanez I, Khabouth J, Khawaja S, Beaino L, Asmar R

Vascular Health and Risk Management 2011, 7:709-717

Published Date: 30 November 2011

Lapatinib: new opportunities for management of breast cancer

Julia Liao, Michelle Gallas, Mark Pegram, et al

Breast Cancer: Targets and Therapy 2010, 2:79-91

Published Date: 15 November 2010